Skip to main content

ARMISTICE CAPITAL, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1601086 NEW YORK, NY

Position in REGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$55,999,503
+$28,087,111 QoQ
Shares Held
89,809
+148.6% QoQ
Ownership
0.087%
of shares outstanding
% of Portfolio
1.55%
of 13F equity value
Holder Rank
#118
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ARMISTICE CAPITAL, LLC holds $1,506,954,940 across 50 Biotechnology names. REGN ranks #11 (3.7% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in REGN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $55,999,503 89,809
2026-03-31 $27,912,392 36,126
2025-12-31 $64,837,080 84,000
2025-09-30 $70,399,577 125,206
2025-06-30 $52,516,800 100,032
2025-03-31 $72,348,518 114,073
2024-12-31 $19,977,294 28,045
2024-09-30 $21,058,439 20,032
2024-06-30 $12,679,625 12,064
2024-03-31 $22,124,757 22,987
2023-12-31 $52,697,400 60,000
2023-09-30 $61,720,354 74,998
2023-06-30 $89,098,960 124,000
2023-03-31 $42,726,840 52,000
2022-12-31 $79,363,900 110,000
2022-09-30 $93,686,320 136,000
2022-06-30 $111,132,440 188,000
2022-03-31 $58,667,280 84,000
2021-12-31 $73,256,320 116,000
2021-09-30 $60,518,000 100,000
2021-06-30 $87,132,240 156,000
2021-03-31 $82,799,500 175,000
2020-12-31 $63,770,520 132,000
2020-09-30 $47,021,520 84,000
2020-06-30 $42,408,200 68,000
2020-03-31 $31,250,560 64,000